Atria Investments LLC acquires 6,943 shares of Walgreens Boots Alliance, Inc. (NASDAQ: WBA )

Atria Investments LLC increased its stake in Walgreens Boots Alliance, Inc. (NASDAQ: WBA – Get a rating) by 10.0% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 76,385 shares of the pharmacy operator’s stock after acquiring an additional 6,943 shares during the period. Atria Investments LLC’s holdings in Walgreens Boots Alliance were worth $2,895,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the business. GoalVest Advisory LLC raised its stake in Walgreens Boots Alliance by 10,828.6% in the second quarter. GoalVest Advisory LLC now owns 765 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 758 shares during the period. WFA of San Diego LLC acquired a new stake in Walgreens Boots Alliance during the second quarter worth about $32,000. Tompkins Financial Corp boosted its holdings in Walgreens Boots Alliance by 215.7% during the first quarter. Tompkins Financial Corp now owns 947 shares of the pharmacy operator’s stock valued at $42,000 after acquiring an additional 647 shares during the period. Tcwp LLC acquired a new stake in Walgreens Boots Alliance during the first quarter worth about $51,000. Finally, Valley National Advisers Inc. boosted its holdings in Walgreens Boots Alliance by 476.0% during the first quarter. Valley National Advisers Inc. now owns 1,152 shares of the pharmacy operator’s stock valued at $52,000 after acquiring an additional 952 shares during the period. Currently, 57.33% of shares are owned by institutional investors.

Analysts set new price targets

A number of research firms have issued reports on WBA. Royal Bank of Canada cut their price target on shares of Walgreens Boot Alliance from $42.00 to $36.00 and set a “sector perform” rating for the company in a report on Wednesday, October 19th. JPMorgan Chase & Co. upgraded shares of Walgreens Boots Alliance from a “neutral” rating to an “overweight” rating and set a $42.00 price objective for the company in a research report on Friday. UBS Group cut their price target on shares of Walgreens Boot Alliance from $40.00 to $37.00 and set a “neutral” rating for the company in a research report on Friday, October 7th. Mizuho cut their target price on shares of Walgreens Boot Alliance to $36.00 in a research report on Thursday, October 13th. finally StockNews.com cut shares of Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Wednesday, October 5th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $42.54, according to MarketBeat.com.

Walgreens Boots Alliance price performance

WBA opened at $39.75 on Monday. Walgreens Boots Alliance, Inc. has a one year low of $30.39 and a one year high of $55.00. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.75, and a quick ratio of 0.38. The 50-day simple moving average is $35.00, and the 200-day simple moving average is $38.14. The stock has a market cap of $34.38 billion, a P/E ratio of 7.95, a price-to-earnings ratio of 1.77 and a beta of 0.71.

Walgreens Boots Alliance (NASDAQ: WBA – Get a rating) last published its quarterly earnings results on Thursday, October 13th. The pharmacy operator reported $0.80 EPS for the quarter, topping the consensus estimate of $0.77 by $0.03. The company had revenue of $32.45 billion for the quarter, compared to analysts’ expectations of $32.17 billion. Walgreens Boots Alliance had a net margin of 3.27% and a return on equity of 14.39%. Walgreens Boots Alliance’s revenue was down 5.3% compared to the same quarter last year. For the same period last year, the firm earned $1.17 in earnings per share. Sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 4.5 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 12th. Shareholders of record on Tuesday, November 15th will be paid a dividend of $0.48 per share. The ex-dividend date of this dividend is Monday, November 14th. This amounts to $1.92 in annualized dividends and a dividend yield of 4.83%. Walgreens Boots Alliance’s dividend payout ratio is 38.40%.

About Walgreens Boots Alliance

(Get a rating)

Walgreens Boots Alliance, Inc. operates as an integrated healthcare, pharmacy and retail service in the United States (US), the United Kingdom, Germany and internationally. It operates through three segments: US Pharmacy Retail, International and US Healthcare. The U.S. Retail Pharmacy segment sells prescription drugs and a range of retail products, including health, wellness, beauty, personal care, consumables and general merchandise through its retail pharmacies.

Selected articles

Want to see what other hedge funds hold WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ: WBA – Get a rating).

Get Walgreens Boots Alliance news and ratings daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Walgreens Boots Alliance and related companies MarketBeat.com’s FREE Daily E-Newsletter.